Delivery Order SPE2DB22D2206-SPE2DB25FEA95
Award Date
11/1/24
Potential Completion Date
11/25/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,259.50 firm fixed price delivery order is for the supply of SCEMBLIX 40 MG TABLET medication. The contract has an ultimate completion date of March 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,304.14 firm fixed-price delivery order is for the supply of SCEMBLIX 40 MG TABLET medication, with a completion date of November 14, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,259.50 firm fixed-price delivery order contract is to provide SCEMBLIX 40 MG TABLET UU 60S, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $13,259.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,259.50 delivery order contract is for the provision of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of March 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $14,946.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 100 MG TABLET, a pharmaceutical product, with a completion date of February 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $14,946.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,259.50, is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract is a firm fixed-price arrangement with a period of performance through July 24, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $24,304.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SCEMBLIX 40 MG TABLET UU 60S. The contract is a firm-fixed price delivery order with an ultimate completion date of October 29, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by various agencies, including the DLA Troop Support Medical and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,259.50, is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...